Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of metabolic syndrome variant in the malignant tumors progression.

Diabetes & metabolic syndrome - 1 Sept 2018

Yunusova Natalia V, Kondakova Irina V, Kolomiets Larisa A, Afanas'ev Sergey G, Kishkina Anastasia Yu, Spirina Liudmila V

Abstract excerpt

Metabolic syndrome (MS) is one of the leading risk factors for the development of some common cancers (endometrial cancer, postmenopausal breast cancer, colorectal cancer). Currently, a drug-induced metabolic syndrome related with androgen deprivation therapy in patients with prostate cancer represents a serious medical problem. Not only MS, or its individual components, but MS variants with different levels of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leptin

Share to Metabolic Syndrome

Share to Neoplasm Invasiveness

Share to Nicotinamide Phosphoribosyltransferase

Share to Risk Factors

Source

Identifiers

PMID: 29699953
DOI: 10.1016/j.dsx.2018.04.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of metabolic syndrome variant in the malignant tumors progression.PMID 29699953Read ↗

Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors)Semantic proximity Read ↗

Association between metabolic syndrome and 13 types of cancer in Catalonia: A matched case-control studySemantic proximity Read ↗

miRNAs in nutrition, obesity, and cancer: The biology of miRNAs in metabolic disorders and its relationship with cancer developmentSemantic proximity Read ↗

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers.Semantic proximity Read ↗

Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping ReviewSemantic proximity Read ↗

How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From MetabolomicsSemantic proximity Read ↗

Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortalitySemantic proximity Read ↗

Assessment of the environmental and genetic factors influencing prevalence of metabolic syndrome in Saudi Arabia.Semantic proximity Read ↗

Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer.Semantic proximity Read ↗

Body mass index-associated molecular characteristics involved in tumor immune and metabolic pathwaysSemantic proximity Read ↗

Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma.Semantic proximity Read ↗

The Unique Relationship between Body Mass Index and Metabolic Syndrome in AIDS PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.